News

Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the following day. Its shares closed the trading session more than 4%

Trading in AstraZeneca's (NASDAQ: AZN) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a U.S. exchange. Investors clearly

Over the past year, Apple (NASDAQ: AAPL) and Amgen (NASDAQ: AMGN), two well-established companies that are part of the iconic Dow Jones Industrial Average, have faced significant headwinds. Apple is

When it comes to popular healthcare stocks, investors have focused a lot of attention lately on Eli Lilly and Novo Nordisk and the potential of their blockbuster weight management treatments

As the old saying goes, "Sometimes, it's better to be lucky than to be good."

Take investors in the Voyager Technologies (NYSE: VOYG) initial public offering (IPO), for example. Once upon a time

What's the biggest misconception about investing? The idea that you need a lot of money to get started is certainly a contender. The reality is that it doesn't take much up-front cash.

Three

Spending on artificial intelligence (AI) infrastructure continues to rise, setting the stage for companies in the AI chip space to outperform over the coming years. The growth in AI infrastructure

Make no mistake, investors love revenue growth, and investing in companies that are growing their top lines quickly can be quite rewarding. 

Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ:

Over the last two years, semiconductor powerhouse Nvidia (NASDAQ: NVDA) has emerged as the biggest force fueling the artificial intelligence (AI) revolution. The company's industry-leading graphics

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and Nvidia (NASDAQ: NVDA). To learn more, check out the short video, consider subscribing, and click the

Over the past year, Editas Medicine (NASDAQ: EDIT) and Sarepta Therapeutics (NASDAQ: SRPT), two biotech companies, have encountered severe headwinds that aren't at all related to broader market

Shares in genetic testing company GeneDx Holdings (NASDAQ: WGS) continued their wild ride in 2025 and are up almost 34% on the week to Friday morning. This week's move follows the American Academy

In this video, I will cover recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.

*Stock

Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move likely stems from the market digesting the previous day's news that Viking had

Palantir Technologies (NASDAQ: PLTR) soared 85% this year as of June 23. The data analytics company expects to grow its top line by more than 36% in 2025 as its robust artificial intelligence (AI)

The latest biotech stock to explode in price, Nektar Therapeutics (NASDAQ: NKTR) was quite the outperformer on the stock exchange for the second day in a row. On Wednesday, one day after delivering

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.

The average stock on the S&P 500 yields just 1.3%. That's a modest return on your money, but that's only the average. There are many dividend stocks that pay you much more than that. While you don't

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD), Super Micro Computer (NASDAQ: SMCI), and other semiconductor stocks. To learn more, check out the short

Cathie Wood kicked off the new trading week with one of her busiest shopping days of 2025. The CEO, co-founder, and ace stock picker at Ark Invest added to 15 of her existing stakes -- including